powered by StockChartsAI.com

All Charts and Prices Based on Previous Days Close



Enter Stock Symbol to View AI powered Stock Chart

By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site.

Insulet Corporation (PODD)

Industry: Medical Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes Website

Instituions

Institution %: 106.401

YTD Institution change: -10100947

Insiders

Insiders %: 0.417

Insiders Purchases YTD: 5551

Insiders Sales YTD: 84719

Insiders Net YTD: -79168

Analyst Ratings

Target Price: 257.94

Overall Rating: 4.2727

Strong Buys (5): 12

Buys (4): 4

Holds (3): 6

Sells (2): 0

Strong Sells (1): 0


Technicals

52 Week Hi: 335.91

52 Week Low: 125.82

Beta: 0.826

50 Day MA: 155.6714

200 Day MA: 246.6997

Earnings / Revenue Trends

Qtr Earnings Growth YOY: -0.15

Qtr Revenue Growth YOY: 0.27

Forward PE:

Trailing PE: